About Platte Valley Womens Healthcare
Services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
Other contracted prescribing entity
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
Drug Enforcement Agency (DEA)
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid; SAMHSA funding/block grants
Special Programs/Groups Offered
Young adults; Adult women; Pregnant/postpartum women; Seniors or older adults; Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ); Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Clients who have experienced sexual abuse; Clients who have experienced intimate partner violence, domestic violence; Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug or alcohol urine screening; HIV testing; STD testing; Metabolic syndrome monitoring; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV)
Transitional Services
Naloxone and overdose education
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Family counseling; Marital/couples counseling
Facility Smoking Policy
Smoking permitted without restriction
Gender Accepted
Female
Facility Vaping Policy
Vaping permitted without restriction
Ancillary Services
Integrated primary care services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
Other contracted prescribing entity
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
Drug Enforcement Agency (DEA)
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid; SAMHSA funding/block grants
Special Programs/Groups Offered
Young adults; Adult women; Pregnant/postpartum women; Seniors or older adults; Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ); Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Clients who have experienced sexual abuse; Clients who have experienced intimate partner violence, domestic violence; Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug or alcohol urine screening; HIV testing; STD testing; Metabolic syndrome monitoring; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV)
Transitional Services
Naloxone and overdose education
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Family counseling; Marital/couples counseling
Facility Smoking Policy
Smoking permitted without restriction
Gender Accepted
Female
Facility Vaping Policy
Vaping permitted without restriction
Ancillary Services
Integrated primary care services
